OpenVSafe by OpenVAERS
Search V-safe

DZA-54579-71544

2 vaccinations 2 coded responses 21 check-ins 0 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
840 / UT
Registered
2023-01-25
Relationship
Child or adolescent in my care
Guardian
QN8-13354-37463
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2023-01-24
    Dose 1 — Pfizer-BioNTech
  2. 2023-01-25
    Registered in v-safe
  3. 2023-01-25
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Eczema — Feeling: Good · Sleepiness
    MedDRA releases: 2024-11
  4. 2023-01-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2023-01-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2023-01-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Diarrhea
    Under 3 check-in
  7. 2023-01-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2023-01-30
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2023-01-31
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2023-02-09
    Survey response — day 14, dose 1, under 3
    MedDRA: Nasopharyngitis — Feeling: Fair
    MedDRA releases: 2024-11
  11. 2023-02-14
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2023-02-28
    Dose 2 — Pfizer-BioNTech
  13. 2023-02-28
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · Site: Pain · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  14. 2023-03-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Pain · Irritability/crying, Loss of appetite, Rash, not including the immediate area around the injection site
    Under 3 check-in
  15. 2023-03-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  16. 2023-03-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2023-03-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2023-03-09
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2023-03-14
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2023-03-21
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2023-03-28
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2023-04-04
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2023-04-11
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2023-05-30
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12023-01-24Pfizer-BioNTech No
22023-02-28Pfizer-BioNTech No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SROEczema · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…